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Objectives:  The  purpose  of  this  study  is  to  map  and  analyze  the content  and  quality  of the
encounter  when  customers  buy  non-prescription  medicines  for pain  and  fever.
Methods:  297  pharmacies  and  801  general  sales  stores  (GSS)  in  Sweden  were  selected.  A
“Mystery shopper”  exercise  was  conducted.  Three  scenarios  were  used  and  a total  of 366
units were  selected  for  each  scenario.  There  were  in  total  625  observers:  208  in the  child
with  fever  scenario,  225  in  the  Reliv  scenario,  and  192  in the  painkiller  during  pregnancy
scenario.  Data  collection:  21st  September  to 20th  November  2011.
Results:  In two out of  three  visits  to  GSS,  the  staff  proposed  a medicine  for  a heavily  pregnant
woman.  The  staff  suggested  in  9% of the  visits  a medicine  that is inappropriate  in late
pregnancy.  The  corresponding  percentage  in  pharmacies  was  1%.
Both  pharmacies  and  GSS  proposed,  in  6% a medicine  that  is  inappropriate  for babies  to
a feverish  child.  Only  16%  of the  pharmacists  and  14% of  the  staff  in  GSS  asked  for  the  age
of the  child.
General sales  staff  recommended  in  10%  ibuprofen  and  in 4% an  acetylsalicylic  acid prod-
uct when  an  acetaminophen  preparation  was  requested.  The  corresponding  percentage  in
the  pharmacy  were  4%  ibuprofen,  2%  diclofenac,  and  1%  an  acetylsalicylic  acid  product.
Conclusions:  The  staff  in  GSS  and  pharmacies  do not  pay  sufﬁcient  attention  to  the  hetero-
rs,  whgeneity of  painkille
. Introduction
Non-prescription medicines are an important part of the
reatment of minor ailments and can be said to relieve the
urden on the health care system. A follow-up of how non-
rescription medicines are recommended to the public is
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of great importance to ensure that the sale is appropriate
with respect to patient safety and public health.
When the Swedish pharmacy market was  deregulated,
the sale of non-prescription medicines for the treatment
of minor ailments was no longer restricted to pharmacies.
The state investigation that led to the reform saw sales
in and outside the pharmacy as supplementary systems
on a deregulated market. The focus was  the patient and
consumer perspective, together with the overall goals of
increased availability, pricing pressure, and safe and effec-
Open access under CC BY-NC-ND license.tive medication use.
According to the legislation, selected non-prescription
medicines may  under certain conditions since November
1, 2009 be sold in general sales stores (GSS) e.g., grocery
alth PoliC. Bardage et al. / He
stores and petrol stations [1–3]. The decision on which
non-prescription medicines that may  be sold outside phar-
macies is taken by the Medical Products Agency (MPA), the
regulatory authority. In connection with the purchase of
these non-prescription medicines, clients have access to
various kinds of information to facilitate their use; such
as written information in the package, verbal information
from personnel in the GSS, and advice from the pharmacist
in a pharmacy [4].  Only in pharmacies there is a require-
ment that pharmaceutical staff should be available during
the store’s opening hours. There are, however, no detailed
requirements on how such staff should be allocated, such
as that staff with client contact, related to non-prescription
medicines should have pharmaceutical expertise. Pharma-
cies in Sweden most often have their shop area divided
into a self-care area and a prescription area. In the self-
care area there are pharmacy technicians working, and they
are obliged to have a pharmacist who they can contact if
needed. Swedish pharmacists are of two kinds, one with
ﬁve years of pharmacy education (equal to the EU directive)
and one with three years. The regulation does not distin-
guish between the two. The pharmacy technicians have an
undergraduate pharmacy education, and in most case an
in-company special training focusing on non-prescription
medicines.
The Government Bill 2008/09: 190 Trade with certain
prescription medicines states that “The operator of GSS
who is a non-pharmacist should not give counseling on the
dosing of medicines. This should be obvious to the vendors
who do not have pharmaceutical knowledge. In view of the
foregoing, the Government is not justiﬁed by any restric-
tion of freedom of expression proposed by the Inquiry.
There may  be situations where a consumer needs advice on
the purchase of non-prescription medicines e.g., questions
about interactions with other drugs that the consumer
uses. At such times it is important that the information is
given by people who have pharmaceutical expertise [3].”
In addition, in the guide where the MPA  stated their
interpretation of the Bill, the agency has included that the
staff in grocery stores should not give advice on choice of
medicines. The legal status of this is not absolutely clear
since it has not been tested at court. The MPA  has the overall
responsibility for how the shops selling non-prescription
medicines live up to the recommendations made by the
authority. The authority is expected to ﬁle a lawsuit against
shops that does not follow the recommendations, but so far
there has been no lawsuit against a shop not following the
regulations decided by the authority, so the exact status of
the recommendations is not ﬁnally decided [4].
Deregulation of prescription medicines is a common
phenomenon all over the world. Little is however known
about the effects of these reforms on customer informa-
tion and counseling. In Israel, most consumers continued
to purchase their non-prescription drugs at pharmacies
after a deregulation [5].  A Belgian study showed that cus-
tomers buying non-prescription medicines were satisﬁed
with the service provided in pharmacies, but skeptical
of other distribution channels [6].  The counseling given
in Swedish pharmacies in connection to non-prescription
sales of medicines has previously been shown to be of
high quality [7].  According to a recent report from thecy 110 (2013) 76– 83 77
Swedish Consumers Agency after the deregulation in 2011,
the opinions of the general public have however become
less positive as compared to a study during the monopoly
in 2008 [8].
We have not found any studies mapping the counseling
of GSS personnel to customers buying medicines. Studies
about staff behavior in relation to sales of non-prescription
medicines have solely been conducted with the pharmacy
as the study object.
There is however a need for this kind of study since the
quality of the advice given and the behavior of the person-
nel in general stores might affect public health, quality of
life of the customer and health care costs.
The MPA  decided in summer 2010 to monitor how the
store staff at both pharmacies and GSS responded to cus-
tomers who intended to buy non-prescription medicines.
The study has been performed by scientists at the author-
ity with the exception of the data collection process, which
has been done by an external company. The study is not
part of the authority’s monitoring within the framework of
the authority’s role as inspectorate, but part of the author-
ity’s responsibility to follow up on how medicines are being
used in the Swedish society.
2. Aim
The purpose of this study is to map  and analyze the
content and quality of the encounter when customers buy
non-prescription medicines for pain and fever. This study
highlights issues related to staff recommendations on the
choice of medicines, staff counseling, questions put to the
customers, and information provided by staff to customers.
3. Materials and methods
Data collection was  done by observers who pretended
to be customers (known as mystery shoppers, simulated
patients or pseudo-customers) [9].  Mystery shopping has
been successfully used in several studies including studies
of pharmacists’ behavior during counseling [10–18].  The
advantage of this method is that it gives results that, as far
as possible, reﬂect a real situation. The disadvantage is that
it is relatively expensive and that there may  be differences
in interpretation of the content of the observation, between
different observers and between different observations
even if they are performed by a single observer. To avoid
this, observers that are trained and carefully instructed are
used for the data collection.
3.1. Observers
Each observer performed a maximum of three observa-
tions. There were in total 625 observers; 208 in the child
with fever scenario, 225 in the Reliv scenario, and 192
in the painkillers during pregnancy scenario. All observa-
tions conducted by the same individual referred to a single
scenario. The observers were mostly women (61%) and
18–70 years. Staff and observers were not familiar with
each other.
The observer chose day and time of observation them-
selves. Based on the agreed and predeﬁned observation
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hart, the observers recorded what happened at the
ustomer encounter. As the observations were to be real-
stic, the observer purchased medicines. The purchase
as reported to Daymaker AB (the company where the
bservers were employed that is specializing in Mystery
hopping studies) and the company could thus ensure that
he observer visited the correct pharmacy or GSS by check-
ng the date and time of the observation. The observer was
ot allowed to buy any medicines other than the medicines
he scenarios focused on. The data was collected by Day-
aker AB ensuring that information on all retail units, was
ompletely anonymous when the information was  submit-
ed to the MPA.
.2. Number and content of the observations
There were 1248 approved pharmacies in Sweden on
he 5th of April 2011 when the number of observations was
etermined. GSS who reported (the stores do not have to be
pproved, but they were obliged to report their intention
o sell medicines to the MPA) trading in non-prescription
edicines were 6152. Of these, 1098 stores (297 pharma-
ies and 801 GSS) were selected for the study.
When the customer came into the store, he/she con-
acted any member of staff and opened a dialog by asking
or a medicine. Three scenarios were used; “I would like to
ave a medicine for my  child/grandchild who has a fever”
“Child with fever”), “I would like to have a package of
eliv” (an unusual acetaminophen product) (“Reliv”), and
I would like to have painkillers for my  wife/partner/friend
ho is soon to have a child” (“Pain tablets during preg-
ancy”) (Table 1). For each scenario, a detailed instruction
as presented to the observers with guidance for the
eplies the observer should give when questions were
sked by the staff. The instructions included e.g. that if the
taff asked for the age of the child in the scenario “Child
ith fever” the observer should reply “She/he is soon to
e 3 months”, if asked “Do you have a sensitive stom-
ch/problems with your stomach?” in the scenario “Reliv”,
he observer were told to reply “Yes, I have a bit of a sensi-
ive stomach”, and if asked of location of the pain in the
cenario “Pain tablets during pregnancy”, the staff were
old to say “I don’t know, I was just told to buy painkillers”.
n all scenarios, the observer were told to answer “No” to
ny question concerning whether the customer had been in
ontact with health care, or have received any counseling
t a pharmacy.
The scenarios are limited to highlighting issues in the
eld of ‘pain and fever’. The test of the realism in the
able 1
istribution of scenario by type of store.
Scenario Abbreviation used 
“I would like to have a medicine for my
child/grandchild who  has a fever”
‘Child with fever’ 
“I  would like to have a package of
Reliv”
‘Reliv’ 
“I  would like to have painkillers for my
wife/partner/friend who  is soon to
have a child”
‘Pain tablets during pregnanc
Total  y 110 (2013) 76– 83
scenarios and the clarity in how they were presented
was  done by sending out test observers at two  different
times with adjustment of the guidelines of the scenarios
in between. The relevance in relation to patient safety was
tested by three of the MPA’s medical experts, who  inde-
pendently analyzed the scenarios from a patient safety
perspective, responding to questions such as “Were the
chosen scenarios highly relevant from a patient safety per-
spective?” and “Are there other scenarios that you would
rather chose from this perspective?”
For each scenario, a simple random sample was  drawn
from the populations of pharmacies and GSS. If a store had
closed or was  not carrying medicines at all (as detected
by the observer) another store was randomly drawn from
the store population in question. A total of 366 units
(Table 1) were selected for each scenario. Data collec-
tion took place during the period: 21st September to 20th
November 2011.
3.3. Rational for choice of scenarios
Medicines for pain and fever are used by many people
and are among the medicines that account for the highest
sales ﬁgures in GSS in Sweden [19]. These are medicines
for which the choice of substance is important as effects,
patterns of adverse events, and recommended use may
differ between the various substances. Certain substances
such as acetylsalicylic acid and ibuprofen should for exam-
ple not be used by women  in late pregnancy, and not by
infants younger than 6 months. Preparations containing
acetaminophen is the analgesic recommended to be used
by people with a sensitive or vulnerable stomach, and to
those who, for various reasons, have a higher risk of bleed-
ing such as people at the end of a pregnancy. Also for infants
acetaminophen is the recommended substance due to the
lower risk of side effects. There is also as high risk of dou-
ble medication since analgesics are labeled in the shops as
medicines for pain and fever, without any differentiation
between substances [20].
Reliv is according to sales statistics an unusual
acetaminophen preparation. It was chosen because we
wanted to see how the staff handled the situation, when
a product that they did not have in store was requested.
Would they propose an alternative acetaminophen prepa-
rations or a product containing another substance?
In the other two scenarios the staff were faced with a
medical problem. The customer asked for a medicine to
relieve pain and fever. In this case the staff at the GSS should
Pharmacies General sales stores Total
101 265 366
102 264 366
y’ 94 272 366
297 801 1098
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Table 2
Proportion of visits at pharmacies and general sales stores (GSS) in which one or several drugs were recommended for purchase during the scenario. Drugs
are  given in the form of the active substance they contain. Percentage ﬁgures in brackets show the proportions in which the substance is recommended as
one  of several options.
Substances in the medicines
recommended
Scenario “Children with fever” Scenario “Reliv” Scenario “Pain tablets
during pregnancy”
Pharmacy
N = 101
GSS N = 265 Pharmacy
N = 102
GSS N = 264 Pharmacy
N = 94
GSS N = 272
Acetaminophen 82%(4%) 57%(4%) 59%(10%) 22%(31%) 94%(3%) 38%(16%)
Ibuprofen 6%(5%) 5%(3%) 4%(10%) 10% (28%) –a (3%) 3% (13%)
Acetylsalicylic acid
combinations
–a 1% (1%) 1% (1%) 4% (13%) 1% (–%) 6% (7%)
Diclofenacb –a –a 2% (–%) –a –a –a
Health food
preparations
–a –a –a 0%a (–%) –a 1% (0%)
The  personnel gave no
recommendation for
7% 34% 25% 33% 2% 35%
less thanany medicine
a “0%” means that the preparation was suggested in a few visits, but at 
b Diclofenac may  be sold only in pharmacies.
direct the customer to a pharmacist in a pharmacy or to
another health care professional.
3.4. Statistical analysis
The data was analyzed using the statistical package SAS.
Frequency distributions were developed.
4. Results
4.1. Staff product recommendation/proposal to
“customer” during the visit
The staff in the shops outside pharmacists were non-
pharmacists. In the pharmacies the staff might in some case
have been a pharmacist, but in most cases a pharmacy tech-
nician. It was in most cases not possible for the observer to
know which one it was since the title is written in small
letters on a small badge on the coat that the staff wears.
The results show that recommendations for products
were made in 74% of all visits, 68% of visits to GSS and
90% in pharmacies. Overall, acetaminophen was the sub-
stance that was suggested most frequently, although it was
more common in pharmacies than in GSS. It was suggested
at 63% of all visits. At 89 visits (8%) acetyl salicylic acid
was recommended/suggested. Ibuprofen was proposed at a
total of 195 visits (18%). In cases where staff recommended
two or more medicines, an acetaminophen preparation was
usually one of the proposals. In two cases the staff at the
pharmacies recommended a diclofenac preparation when
the customer requested Reliv.
Table 2 shows that in the scenario “Child with fever” the
staff, both in pharmacies and in GSS, proposed a medicine
containing an inappropriate substance i.e., ibuprofen or
acetylsalicylic acid combinations in 6% of the visits.
In the scenario “Reliv”, a substance other than the active
substance contained in Reliv was proposed i.e., ibupro-
fen or acetylsalicylic acid combinations as the only option
at 14% of visits to GSS. During visits to pharmacies, the
corresponding proportion was 7%. In addition, diclofenac,
another inappropriate substance, was offered as a sole 1% of the visits. “–” means that the preparation was not suggested at all.
alternative in 2% of the visits to pharmacy. In 25% of the
pharmacy visits the customer was not offered any recom-
mendation at all.
In the scenario “Pain tablets during pregnancy” inap-
propriate medicines were suggested as the only option at
10% (including 1% health products) of visits to GSS. During
visits to pharmacies the corresponding proportion was 1%.
4.2. Counseling “customers” during the visit
In addition to recommending or suggesting medicines,
staff at the pharmacy and the GSS also gave advice to the
“customers”, for example, to contact a pharmacist or other
health care professional.
The counseling on medicines was the most common
piece of advice in pharmacies. In the GSS the staff said at
10% of the visits that they were not allowed to give advice,
the corresponding ﬁgure in pharmacy is 1%. The staff at
GSS referred to a pharmacy in 8% of the visits as the sole
advice and in 11% as an addition to some other advice. Staff
in pharmacy are more likely than staff in GSS to refer to a
health care professional.
In Table 3 it is seen that in the scenario “Child with fever”
the staff in the GSS gave no counseling at all in 58% of the
visits. During 5% of the visits the “customer” was advised
to contact a doctor/healthcare professional, and in 19% a
pharmacist. At 11% of the visits the staff in GSS indicated
that they must not give advice about medicines. At phar-
macies, the corresponding proportion in which there was
no advice given was 56%. At 17% of the visits, the advice
was to contact a doctor or health care professional.
In 78% of visits in the scenario “Reliv” the staff of the GSS
gave no advice to “customers” at all and at 3% of the visits
the “customer” was  advised to contact a pharmacist. In the
same scenario, the staff at the pharmacy gave no advice
in 72% of the visits. In 3% of the visits “customers” were
advised to contact a doctor or health care professional.In the scenario “Pain tablets during pregnancy” the
staff in GSS gave no advice in 53% of the visits and in 6%
of the visits staff gave the advice to ask a doctor/health
care professional, and in 10% to contact a pharmacist. The
80 C. Bardage et al. / Health Policy 110 (2013) 76– 83
Table 3
Did you receive any advice during your visit? (e.g., advice on exercise, rest, special diets, herbal medicine, other drugs, etc.) by different store types.
Percentage ﬁgures in brackets show the proportions in which the advice/recommendation is one of several.
Type of advice Scenario “Children with fever” Scenario “Reliv” Scenario “Pain tablets
during pregnancy”
Pharmacy
N = 101
GSS N = 265 Pharmacy
N = 102
GSS N = 264 Pharmacy
N = 94
GSS  N = 272
Advice about medicine 20% (13%) 6% (4%) 16% (4%) 5% (1%) 14% (19%) 6% (1%)
Advice  to contact pharmacy N/A 15%(4%) N/A 2%(1%) N/A 7%(3%)
Advice  against taking medicines (2%) – 2% – 10% (9%) 4% (4%)
Alternative treatment to medicine
recommended
– 1% – – – 1%
Advice  as a complement to
medicines e.g. rest, exercise
1% (4%) 0% (1%) 1% (3%) 0% 1% (3%) (1%)
Advice  to contact a doctor or the
health care professional
6% (11%) 2% (3%) 2% (1%) – 6% (4%) 4% (2%)
The  sales staff say that they may – 6% (5%) 2% (1%) 9% (4%) (1%) 13% (4%)
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No  pieces of advice were given 56% 58% 
“0%” means that the preparation was  suggested in a few visits, but at les
harmacy staff gave no advice in 47% of the visits. In 10%
f the visits the staff gave advice to contact a doctor/health
are professional.
.3. Questions to the “customers” during the visit
At some point during the visit, there may  be the need for
taff to ask questions in order to ﬁnd out which medicines
nd which or what information the customer needs and
ants. Pharmacy staff asked the “customer” questions to a
reater extent than the staff in the GSS at some point dur-
ng the visit, regardless of scenario. The scenarios ‘Children
ith fever’ and ‘Pain Tablets during pregnancy’ generated
ore issues compared to the scenario “Reliv” where, for
xample, questions were asked in only 28% of visits to GSS.
In the scenario ‘Children with fever’ the pharmacist
lmost always (94%) asked a question. The store staff in
he GSS asked questions in just over half of the visits. The
ost common question in any type of store was, “who is the
edicine for?”. This question was however asked more fre-
uently by the pharmacy staff compared to the staff in GSS
55% compared to 24%). The question “how high was  the
hild’s fever?” was asked at 51% of the visits to a pharmacy
nd 14% of GSS staff. The question “how long has the child
ad a fever?” was asked in 42% of visits to a pharmacy and
% of visits to GSS. Pharmacy staff asked more frequently,
f the child is using any other medicine, 13% versus 4%. The
uestion “how old is the child?” was asked by 14% of staff
n GSS, and 16% of staff at the pharmacy.
In the scenario “Reliv” the most common question from
taff both in pharmacies and GSS was “why do you need
ainkillers?” This was asked at 27% of pharmacy visits com-
ared to 15% of the visits to GSS. In pharmacies other
requently asked questions were “have you used Reliv
efore?” (22%) and “who is the medicine for?” (18%). These
uestions were asked less often in GSS (5% and 5% of the
isits). The question “what medication/s do you normally
se?” was asked in 15% of the visits to the pharmacy and in
% of visits to GSS.
In the scenario “Pain tablets during pregnancy” the
harmacist asked questions in two out of three visits. The72% 78% 47% 53%
% of the visits.
store staff in the GSS raised questions in 33% of visits in
this scenario. The most common question at the pharmacy
visits: “where is your wife’s/partner’s/friend’s pain?” This
was  asked in 35% of the pharmacy visits, more often than in
GSS where the question was asked in 11% of the visits. The
question “in what month is your wife/partner/friend?” was
asked in 34% of pharmacy visits, and in 5% of visits to GSS.
In 12% of the visits, pharmacy staff was  asked if there had
been contact with a health care professional, which more
often than at visits to GSS (4%).
4.4. Information provided to “customers” during the visit
“Customers” were informed by the staff based on their
own  knowledge i.e., reciting more frequently in pharma-
cies than in GSS. This occurred at 71% of the visits to the
pharmacy, but only at 26% of visits to GSS in the scenario
“Children with fever.” Staff read aloud from the text on the
package at about one-third of the visits regardless of type
of store. In the GSS, it was  more common than at pharma-
cies that the “customer” did not receive any information at
all, 24% vs. 5%. Staff handed over the package and asked
the “customer” to read him-/herself at 12% of the visits
to the pharmacy and at 19% of visits to GSS. Provision of
written information, such as in the form of a leaﬂet was
relatively uncommon, both in pharmacies and in grocery
stores (Table 4).
In the scenario “Reliv”, it was  more common that
pharmacy staff provided information from their own
knowledge than the staff in the GSS (50% vs. 31%) (Table 4).
In the scenario “Pain tablets during pregnancy” the most
common activity in pharmacies was that the staff provided
information based on their own  knowledge. Pharmacy staff
were also more likely to inform on the basis of their own
knowledge compared to the GSS staff (67% vs. 26% of visits).
The most common in the GSS was  that the staff would read
aloud from the text on the packaging (43% of visits). It was
also common that the staff said that the “customer” could
read her/himself from the packaging (21% of visits). In phar-
macies, it was less common that the staff did so (Table 4).
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Table 4
Proportion of visits in which the customer received any kind of information in the three scenarios at point of sale (multiple answers possible).
Type of information Scenario “Children with fever” Scenario “Reliv” Scenario “Pain tablets
during pregnancy”
Pharmacy
N = 101
GSS
N = 265
Pharmacy
N = 102
GSS N = 264 Pharmacy
N = 94
GSS
N = 272
The sales staff said that the customer can
read on the package him/herself
13% 15% 9% 14% 8% 21%
The  sales staff read aloud to the customer
what it says on the packaging
31% 32% 12% 6% 27% 43%
The  sales staff passed on information, such
as  a leaﬂet
3% 1% 0%a 1% 1% 2%
The  sales staff provided information on
where to look for information, for
example via the Internet
1% 3% 4% 1% 2% 4%
The  sales staff handed over the package
and asked the customer to read
him/herself
12% 19% 13% 13% 15% 15%
The  sales staff provided information from
their own  knowledge
71% 26% 50% 31% 67% 26%
The  customer did not receive any
information
5% 24% 30% 41% 6% 14%
 less thaa “0%” means that the preparation was  suggested in a few visits, but at
It was more common that the “customer” did not receive
any information at all during all the scenarios when visiting
GSS compared to pharmacies.
5. Discussion
When the Swedish pharmacy reform was launched the
politicians and the authorities believed that staff in both
GSS and in pharmacies would follow the given regula-
tions and recommendations. This study shows that this is
far from always the case. Whether the staff in pharmacies
before the reform behaved in a more professional way  than
seen in this study is unknown although the study from the
Swedish consumers Agency supports such a notion [8].  It
is however probable that the pharmacies due to increased
competition as an effect of the increased accessibility of
medicines (more sales spots), which was one of the goals of
the reform, are becoming more commercial and as a con-
sequence put less emphasis on cognitive communication
and information. In Finland, it was shown that consumers
only obtain the counseling for nicotine replacement ther-
apy at pharmacies but buy the products elsewhere, which
has diminished pharmacists’ motivation to counsel, espe-
cially among pharmacy owners [21]. In an Australian study,
counseling was provided in 24% of pharmacy visits to simu-
lated patients asking for a non-prescription asthma reliever
medication. However, in only 4 cases out of 160, pharmacy
staff members asked whether the simulated patient knew
how to use the inhaler [11]. In Germany, at least one ques-
tion was asked in 95% of the cases of symptom presentation
to check on accuracy of self-diagnosis in a study using
trained pseudo customers, but only in 47% of the cases of
speciﬁc product request [12].
Personnel in general sales stores are not supposed to
give advice on choice of medicines yet this study shows
that it is done frequently. Recommendations for speciﬁc
products were made in 68% of the visits to GSS. The reason
for this deviation from authority recommendation mightn 1% of the visits.
be that the store staff are trained to help the customer in
all cases, and not to refer to a competitor. It is neverthe-
less not in line with the policies outlined by the Swedish
government and might affect patient safety in a negative
way. How frequently this happens in other countries is
unknown.
In addition, both GSS and pharmacy personnel gave
advice to the customers in the two  scenarios that were
based on a medical problem that may  have compromised
the safety of those persons if they were to have followed
the recommendation. Such behavior has also been seen
in other countries e.g. New Zealand where a recent study
showed that health food store staff recommended and
sold a wide variety of compounds of unproven efﬁcacy for
hypertension [10].
To offer the customer a preparation containing ibupro-
fen or acetyl salicylic acid when he/she asks for Reliv
(an acetaminophen containing product) is not appropriate
as they are different substances and have slightly differ-
ent effects as well as having different patterns of adverse
events. At the GSS we  expected the staff to tell the customer
to go to a pharmacy (or maybe another shop) since the GSS
staff are not allowed to give any recommendations about
products, and it was  highly unlikely that the shop had Reliv
in stock. At pharmacies the staff was expected to offer the
customer Reliv, or another acetaminophen product which
happened in most cases.
The reason staff working in GSS do not follow authority
instruction is not known, but it is probable that the staff
view medicines more or less like other products. Staff in
GSS are there to sell and to help customers chose a product.
Referring the customer to another and competing shop is
against what they are told to do in other situations and is
probable difﬁcult for them. The results in this study support
this.
The results show furthermore that the behavior of
the pharmacy staff also is in need of improvement.
We assumed that the pharmacy staff should be asking
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uestions more often when customers were demanding
edicines for medical symptoms. This study shows that
his is not always the case. Whether this is due to lack
f competence of the staff working in the self selection
rea, lack of time to reﬂect on the question put forward by
he customer or a general trend toward a more commer-
ial pharmacy market is unknown and needs to be further
nvestigated. In an American study in eight states using
imulated patients, it was shown that busyness reduced
he odds of any pharmacy talk, oral information-giving
nd assessment of understanding. However, more inten-
ive regulations increased the likelihood [13]. In the UK,
ommunication skills of pharmacists were rated highly in
 simulated patient study aimed at assessing the clini-
al and communication skills of community pharmacists
14].
Another question is if the deviations from what could be
xpected from GSS and from pharmacy staff is due to the
harmacy reform. It is clear that before the reform all cus-
omers had to visit a pharmacy to buy their medicines and
ow they can buy them in GSS. But since most Swedish
harmacies for many years have had non-prescription
edicines placed in a self selection area and the customers
re used to choosing products without necessarily receiv-
ng counseling, it could be that the reform only in a minor
ay have affected the counseling given to customers who
uy non-prescription medicines in Sweden. On the other
and, in a pharmacy there is always a pharmacist (MSc or
Sc) present who can answer questions from the customers
f approached. We  do not know if the number of staff per
harmacy with a pharmacy degree has decreased, but since
here are many more pharmacies now and the number of
harmacists who become licensed have not increased there
re probably fewer pharmacists per pharmacy today as
ompared to before the reform who can answer questions
rom the customers.
.1. Methodological discussion
The methodology used in this study (Mystery shopping)
s an accepted method of data collection in terms of
athering information about how trade staff behave. This
pproach has previously been used in Sweden in order to
tudy pharmacists’ advice [15]. The aim is to as far as pos-
ible try to get the observers to behave in the same way
nd to interpret and record similarly. However, observers
re different individuals, which can affect both the store
mployee’s behavior and how the individual interprets
hat is happening.
In this study, more than 300 different observers per-
ormed the observation so that being a customer in this
tudy would not become routine to the observer, which is
 risk if you were to repeat the same scenario many times.
his in turn could negatively affect the realism of the cus-
omer situation. Observers had to respond to words like
ecommendation, advice, information, etc. It is obvious that
 certain difference in interpretation occurred. In this study
e have tried, as far as possible, to verify this by making use
f trained observers and by providing them with detailed
nstructions on how to behave and respond to questions.
[
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6. Conclusions
It is clear from the result in this study that many of
the staff in GSS, and to some extent in pharmacies, do
not distinguish between different types of analgesics in
an appropriate way. This might compromise the safety of
medicines users.
GSS without pharmaceutical or medical competence
should refer customers to the pharmacy, or physi-
cian/medical information, in cases where a medicine is
requested for a medical symptom. The results show that
the pharmacy staff are also in need of improvement. We
believe that the pharmacy staff should be asking questions
more often where customers are demanding medicines for
medical symptoms. This study shows that this is not always
the case.
Ethical approval
The ethical review board in Uppsala has issued an advi-
sory opinion (No. 2011/182) and ﬁnds “after an ethics
investigation that there are no obstacles to carrying out the
research in the application”.
Conﬂict of interest
The authors declare that they do not have any conﬂict
of interest.
References
[1] The Ministry of Health, SOU 2008:33. Retail sale of certain non-
prescription medicines (Swedish). Stockholm; 2008.
[2]  Swedish Code of Statutes (SFS) Act (2009:730) concerning trade in
certain non-prescription medicines. Stockholm; 2009.
[3] The Government. Government Bill 2008/09: 190. Trade with certain
prescription medicines (Swedish). Stockholm; 2009.
[4]  The Medical Products Agency, LVFS 2009:20. Guide for retail sale
of  certain non- prescription medicines (Swedish). Uppsala; 2009.
Available from: http://www.lakemedelsverket.se/upload/lvfs/
vagledningar/V%c3%a4gledning LVFS 2009 20 verksamhetsut%c3%
b6vare 2010 18.pdf [accessed 26.04.12].
[5] Vaknin S, Abadi-Korek I, Marom E, Shemer J, Luxenburg O. The over
the  counter drugs reform in Israel – two years later (Hebrew). Hare-
fuah 2011;150(4–8):70.
[6] Simoens S, Lobeau M,  Verbeke K, van Aerschot A. Patient experiences
of  over-the-counter medicine purchases in Flemish community
pharmacies. Pharmacy World & Science 2009;31:450–7.
[7] Westerlund T, Andersson I-L, Marklund B. The quality of self-care
counseling by pharmacy practitioners, supported by IT-based clinical
guidelines. Pharmacy World & Science 2007;29:67–72.
[8] Swedish Consumers Agency. Deregulation of the Swedish pharmacy
market. Report 2011:9 (Swedish). Stockholm; 2011. Available from:
http://www.konsumentverket.se/Global/Konsumentverket.se/Best%
c3%a4lla%20och%20ladda%20ner/rapporter/2011/2011 9
omregleringen av apoteksmarknaden.pdf [accessed 04.07.11].
[9] Benrimoj SI, Werner JB, Raffaele C, Roberts AS. A system for monitor-
ing quality standards in the provision of non-prescription medicines
from Australian community pharmacies. Pharmacy World & Science
2008;30:147–53.
10] Siebers R, Holt S, Healy B, Beasley R, Burgess C. High blood pres-
sure advice given by natural health food stores. New Zealand Medical
Journal 2009;122(1293):3566.
11] Benrimoj SI, Werner JB, Raffaele C, Roberts AS, Costa FA. Monitor-
ing quality standards in the provision of non-prescription medicines
from Australian Community Pharmacies: results of a national pro-
gramme. Quality & Safety in Health Care 2007;16:354–8.
12] Berger K, Eickhoff C, Schulz M. Counselling quality in community
pharmacies: implementation of the pseudo customer methodology
alth Poli
[
[
[
[
[
[
[
[
[21] Kurko T, Linden K, Vasama M, Pietilä K, Airaksinen M.  Nico-C. Bardage et al. / He
in  Germany. Journal of Clinical Pharmacy and Therapeutics
2005;30:45–57.
13] Svarstad BL, Bultman DC, Mount JK. Patient counseling provided
in community pharmacies: effects of state regulation, pharmacist
age, and busyness. Journal of the American Pharmacists Association
2004;44:22–9.
14] Weiss MC,  Booth A, Jones B, Ramjeet S, Wong E. Use of simulated
patients to assess the clinical and communication skills of commu-
nity pharmacists. Pharmacy World and Science 2010;32:353–61.
15] Tully MP,  Beckman Gyllenstrand A, Bernsten CB. Factors predicting
poor counseling about prescription medicines in Swedish commu-
nity pharmacies. Patient Education and Counseling 2011;83:3–6.
16] Watson MC, Skelton JR, Bond CM,  Croft P, Wiskin CM,  Grimshaw JM,
et  al. Simulated patients in the community pharmacy setting, Using
simulated patients to measure practice in the community pharmacy
setting. Pharmacy World and Science 2004;26:32–7.
17] Schneider CR, Everett AW,  Geelhoed E, Kendall PA, Clifford RM.  Mea-
suring the assessment and counseling provided with the supply ofcy 110 (2013) 76– 83 83
nonprescription asthma reliever medication: a simulated patient
study. Annals of Pharmacotherapy 2009;43:1512–8.
18] Mesquita AR, Lyra Jr DP, Brito GC, Balisa-Rocha BJ, Aguiar PM,  de
Almeida Neto AC. Developing communication skills in pharmacy: a
systematic review of the use of simulated subject methods. Patient
Education and Counseling 2010;78:143–8.
19] The Medical Products Agency’s side effects data system, The Swedish
Medicine Information System (SWEDIS) [accessed 15.08.12].
20] Wilson Km,  Singh P, Blumkin AK, Dallas L, Kein JD. Knowledge gaps
and  misconceptions about over-the-counter analgesics among ado-
lescents attending a hospital-based clinic side effects. Academic
Pediatrics 2010;10:228–32.tine replacement therapy practices in Finland one year after
deregulation of the product sales – has anything changed from
the community pharmacy perspective? Health Policy 2009;91:
277–85.
